These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38477916)

  • 1. Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer.
    Berg T; Jensen MB; Rossing M; Bechmann T; Donskov F; Knoop AS; Ejlertsen B
    JAMA Netw Open; 2024 Mar; 7(3):e242174. PubMed ID: 38477916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
    Plichta JK; Thomas SM; Hayes DF; Chavez-MacGregor M; Allison K; de Los Santos J; Fowler AM; Giuliano AE; Sharma P; Smith BD; van Eycken E; Edge SB; Hortobagyi GN
    J Clin Oncol; 2023 May; 41(14):2546-2560. PubMed ID: 36944149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Staging System for De Novo Metastatic Breast Cancer Refines Prognostic Estimates.
    Plichta JK; Thomas SM; Sergesketter AR; Greenup RA; Rosenberger LH; Fayanju OM; Kimmick G; Force J; Hyslop T; Hwang ES
    Ann Surg; 2022 Apr; 275(4):784-792. PubMed ID: 32657941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.
    Chan SK; O'Sullivan B; Huang SH; Chau TC; Lam KO; Chan SY; Tong CC; Vardhanabhuti V; Kwong DL; Ng CY; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
    Malmgren JA; Mayer M; Atwood MK; Kaplan HG
    Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
    JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Characterization of
    Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
    Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
    Seltzer S; Corrigan M; O'Reilly S
    Exp Mol Pathol; 2020 Jun; 114():104404. PubMed ID: 32067942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Survival of De Novo Stage IV Human Epidermal Growth Receptor 2 (HER2) Positive Breast Cancers Treated with HER2-Targeted Therapy.
    Wong Y; Raghavendra AS; Hatzis C; Irizarry JP; Vega T; Horowitz N; Barcenas CH; Chavez-MacGregor M; Valero V; Tripathy D; Pusztai L; Murthy RK
    Oncologist; 2019 Mar; 24(3):313-318. PubMed ID: 30139836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
    Gaillard T; Carton M; Mailliez A; Desmoulins I; Mouret-Reynier MA; Petit T; Leheurteur M; Dieras V; Ferrero JM; Uwer L; Guiu S; Gonçalves A; Levy C; Debled M; Dalenc F; Patsouris A; Bachelot T; Eymard JC; Chevrot M; Conversano A; Robain M; Hequet D
    Eur J Cancer; 2021 Oct; 158():181-188. PubMed ID: 34689042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Survival Model Performance Following Inclusion of Epstein-Barr Virus DNA Status in Conventional TNM Staging Groups in Epstein-Barr Virus-Related Nasopharyngeal Carcinoma.
    Li WZ; Wu HJ; Lv SH; Hu XF; Liang H; Liu GY; Lu N; Bei WX; Lv X; Guo X; Xia WX; Xiang YQ
    JAMA Netw Open; 2021 Sep; 4(9):e2124721. PubMed ID: 34554238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.
    Weiss A; Chavez-MacGregor M; Lichtensztajn DY; Yi M; Tadros A; Hortobagyi GN; Giordano SH; Hunt KK; Mittendorf EA
    JAMA Oncol; 2018 Feb; 4(2):203-209. PubMed ID: 29222540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeled Prognostic Subgroups for Survival and Treatment Outcomes in BRAF V600-Mutated Metastatic Melanoma: Pooled Analysis of 4 Randomized Clinical Trials.
    Hauschild A; Larkin J; Ribas A; Dréno B; Flaherty KT; Ascierto PA; Lewis KD; McKenna E; Zhu Q; Mun Y; McArthur GA
    JAMA Oncol; 2018 Oct; 4(10):1382-1388. PubMed ID: 30073321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
    Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
    Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients.
    McKenzie HS; Maishman T; Simmonds P; Durcan L; ; Eccles D; Copson E
    Br J Cancer; 2020 May; 122(11):1618-1629. PubMed ID: 32231292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.